MEDIROM Healthcare (NASDAQ:MRM) reported $23.19 million in sales this quarter. This is a 19.83 percent increase over sales of $19.36 million the same period last year.
Revenue totaled JPY3,147 million in the half-year ended June 30, 2022, an increase of 47.9% from JPY2,127 million in the half-year ended June 30, 2021. This increase was primarily due to revenue
MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare Company based in Japan (the “Company”), announced today that it has received a written notification (the “Notification